NCT07677540 Continuous Erector Spinae Block Versus Thoracic Epidural Analgesia for the Prevention of Chronic Pain Following Thoracotomy: a Retrospective Study
| NCT ID | NCT07677540 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Meir Medical Center |
| Condition | Thoracic Surgery |
| Study Type | OBSERVATIONAL |
| Enrollment | 34 participants |
| Start Date | 2023-09-12 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 34 participants in total. It began in 2023-09-12 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Post-thoracotomy pain syndrome (PTPS) is a prevalent complication that significantly impacts patients' quality of life, with reported incidence ranging from 25% to 90%. This study evaluated the effectiveness of continuous erector spinae plane (ESP) block compared to thoracic epidural analgesia (TEA), the current gold standard, in preventing PTPS. Our goal was to compare the incidence of PTPS between patients who received ESP block and those who underwent TEA. Additional goals included assessing postoperative pain levels, analgesic consumption, and complications related to the anesthesia techniques.
Eligibility Criteria
Inclusion Criteria: 1\. Ages 18-65 years 2. Presenting for elective thoracic surgery under general anesthesia. 3. Undergoing either ESP or TEA prior to surgery. \- Exclusion Criteria:Patients were excluded if they met any of the following criteria: 1\. Any CNS and/or psychiatric disease. 2. Patients who are unable to complete the pain survey for any reason. 3. Patients who had baseline chronic pain around the surgical incision. \-
Frequently Asked Questions
Who can join the NCT07677540 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Thoracic Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07677540 currently recruiting?
Yes, NCT07677540 is actively recruiting participants. Visit ClinicalTrials.gov or contact Meir Medical Center to inquire about joining.
Where is the NCT07677540 trial being conducted?
This trial is being conducted at Kfar Saba, Israel.
Who is sponsoring the NCT07677540 clinical trial?
NCT07677540 is sponsored by Meir Medical Center. The trial plans to enroll 34 participants.